Hyosin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hyosin

What is Hyosin: Core Identity and Classification

Property Description
Active ingredient Hyoscine Butylbromide (INN)
Form Tablets, Ampoules (Injection), Suppositories
Pharmacological class Antispasmodic agent, Anticholinergic drug
General purpose Relief of cramps and smooth muscle spasm
Origin Semi-synthetic derivative

Hyosin, which shares its active substance, Hyoscine Butylbromide, with other popular names like Buscopan, functions as a specialized antispasmodic agent and is classified pharmacologically as an anticholinergic drug. This medicine is widely and clinically recognized for its rapid onset of action in relieving pain caused by involuntary muscle contractions, or spasms, in the internal organs.

The active substance, Hyoscine Butylbromide, is chemically derived from the tropane alkaloid, Scopolamine, but it is specifically structured as a quaternary ammonium compound. This particular chemical distinction prevents the molecule from easily crossing the blood-brain barrier. This is a key differentiating factor from other anticholinergics, as it ensures the medicine primarily focuses its action on the peripheral nervous system—the smooth muscles of the digestive and urinary tracts.


Forms, Origin, and General Purpose

Hyoscine Butylbromide is available as a single-ingredient product supplied in standard dosage forms, including oral tablets and parenteral solutions in ampoules. The availability of both forms supports its general purpose of stopping acute or severe painful cramping.

The drug works by acting as a peripheral relaxant, effectively blocking the nerve impulses that cause the smooth muscles of organs like the stomach, intestines, and bladder to contract uncontrollably. It is recognized as a powerful agent for acute, painful spasms in the abdominal region. The primary general benefit provided is the rapid cessation of visceral muscle spasms, offering targeted relief for sharp, cramp-like discomfort.

Regulatory References

  1. WHO Essential Medicines List for Hyoscine Butylbromide

What side effects are possible with Hyosin?

Possible Side Effects and Safety Information

Hyosin (hyoscine butylbromide) is associated with adverse reactions classified in official regulatory documents based on frequency of occurrence and the system-organ class (SOC) affected. The safety profile reflects the drug's established peripheral anticholinergic activity, which is the primary source of the most common effects.

Adverse reactions are categorized by frequency in official prescribing information:

  • Common Reactions (may affect up to 1 in 10 people) typically involve the Gastrointestinal and Cardiac systems, manifesting as dry mouth and tachycardia (increased heart rate). Accommodation disorders (blurred vision) are also listed in this category.
  • Uncommon Reactions (may affect up to 1 in 100 people) include skin reactions like urticaria (hives) and pruritus (itching), as well as dyshidrosis (abnormal sweating).
  • Rare Reactions (may affect up to 1 in 1,000 people) primarily involve the Renal and Urinary Disorders system, reported as urinary retention.

Several serious reactions are documented in post-marketing surveillance with a Not Known frequency, meaning a precise estimate cannot be made from available data. These include severe anaphylactic reactions and anaphylactic shock, which is a life-threatening event. Other serious but rare events, such as cardiac arrest and severe hypotension, are specifically noted in warnings regarding the injection form, particularly for patients with underlying cardiac disease.

Official labels define strict safety constraints against the use of Hyosin in individuals with conditions that can be worsened by anticholinergic effects. These include narrow-angle glaucoma, myasthenia gravis, megacolon, and mechanical stenosis of the gastrointestinal tract.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information defines the overdose profile of Hyoscine Butylbromide (Hyosin) as an exaggeration of its peripheral effects. Serious signs of poisoning following acute overdosage are generally not observed, but the symptoms mandate prompt medical review.

Documented Overdose Manifestations

System Manifestations Documented in Regulatory Labels
Anticholinergic Signs Tachycardia, dry mouth, reddening of the skin, inhibition of gastrointestinal motility, and transient visual disturbances (accommodation disorders).
Excretory / Respiratory Urinary retention, and the potential for respiratory paralysis or Cheynes-Stokes respiration (reported) are noted in official documents.

Official Emergency Response Requirements

Immediate medical advice must be sought if severe, unexplained abdominal pain persists, worsens, or occurs together with systemic symptoms such as fever, vomiting, or changes in bowel movements. Urgent ophthalmological advice is required if a painful, red eye with loss of vision develops.

In the event of overdosage, symptoms are officially documented as responding to parasympathomimetics. Specific supportive measures include gastric lavage with medicinal charcoal for oral poisoning, and catheterisation to manage urinary retention. Procedures like intubation and artificial respiration are required for the serious complication of respiratory paralysis.

Therapeutic Uses of Hyosin

What Hyosin Treats: Main Uses and Benefits

Hyosin, which contains the active ingredient hyoscine butylbromide, is an antispasmodic medication applied across therapeutic domains where additional symptomatic support is needed. It is commonly used to help with symptoms of increased neurological or muscular activity.

The medication is utilized for easing symptoms related to inflammatory or irritative states such as spasm of the gastro-intestinal tract or genito-urinary tract, and for the symptomatic relief of Irritable Bowel Syndrome (IBS). This is relevant for easing symptoms related to physical discomfort and symptoms that create noticeable physiological strain.

Hyoscine butylbromide is commonly used across conditions presenting with acute episodes of cramping abdominal pain. The medication is applied when appropriate for managing symptoms that become more disruptive during flare-ups. It supports patients during difficult episodes and contributes to easing the overall symptom load.

Quick Fact

Supports patients during episodes of heightened discomfort

Eligibility and Restrictions for Use

Who Can and Cannot Use Hyosin?

The official eligibility profile for hyoscine butylbromide (Hyosin) is strictly defined by regulatory contraindications and age-based restrictions, focusing on patients who must not use the medicine due to inherent risk.

Hyosin is Contraindicated (Must Not Be Used) in Patients With:

Contraindication Category Specific Condition(s)
Neurological/Muscular Myasthenia gravis
Ocular Untreated narrow-angle glaucoma
Gastrointestinal Mechanical stenoses, paralytic or obstructive ileus, or megacolon
Genitourinary Prostatic hypertrophy with urinary retention
Cardiovascular Tachycardia
Hypersensitivity Known allergy to hyoscine butylbromide or its excipients

Restricted and Not Recommended Populations

  • Pediatric Use: The medicine is not recommended for use in children under 6 years of age.
  • Pregnancy and Lactation: Use is not recommended during pregnancy or while breastfeeding due to insufficient data to establish safety.

Eligible users are generally adults and children over 6 years of age who do not present with any of the formal contraindications listed above.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Hyoscine Butylbromide (Hyosin) is formally documented in regulatory prescribing information, focusing on both pharmacodynamic and pharmacokinetic patterns. No specific drug combination is strictly classified as contraindicated based solely on interaction risk.

Documented Drug-Drug Interactions

Interaction Type Interacting Medicines and Mechanism
Pharmacodynamic Reinforcement Co-administration with Tricyclic/Tetracyclic Antidepressants, Antihistamines, Quinidine, Amantadine, and Disopyramide may lead to an additive anticholinergic effect. The medicine may also enhance the cardiac effects of Beta-Adrenergic Agents.
Mutual Antagonism Concomitant use with Dopamine Antagonists (e.g., Metoclopramide) results in the mutual antagonism of effects on gastrointestinal motility.
Pharmacokinetic Hyoscine Butylbromide is a P-glycoprotein (P-gp) substrate. Co-administration with P-gp inhibitors has the potential to increase the systemic exposure (plasma concentration) of the medicine.

Other Substance Restrictions

Regulatory patient information in some regions advises against the consumption of alcohol while using this medicine. No mandatory timing separation rules (e.g., "administer X hours apart") are documented for other co-administered medicinal products.

Mechanism of Action

How Hyosin Works

Hyoscine Butylbromide (Hyosin) acts by a highly specific mechanism to produce smooth muscle relaxation by disrupting excitatory signaling, focusing its effect exclusively on the peripheral nervous system.

The mechanism initiates at the molecular level where Hyosin functions as a competitive antagonist against the body's natural signaling molecule, Acetylcholine (ACh), at the Muscarinic Acetylcholine Receptors ( M1, M2, M3) located on the smooth muscle cells of the gut and genitourinary tracts. This targeted action prevents ACh from binding and transmitting the excitatory nerve impulse, thereby interrupting the primary signaling cascade of the parasympathetic system.

This receptor blockade modifies the crucial cellular step known as excitation-contraction coupling. By preventing the stimulatory signal, the drug inhibits the necessary increase in intracellular ionized calcium ( Ca^2+), which is essential for muscle fiber shortening. This failure to mobilize calcium results directly in smooth muscle relaxation (spasmolysis), which causes a decrease in excessive smooth muscle tone in the visceral organs.

Hyosin's chemical structure as a quaternary ammonium compound makes the molecule highly polar and prevents it from readily crossing the blood-brain barrier (BBB). This constraint limits the drug's activity to the peripheral nervous system and the visceral organs, resulting in minimal modulation of central cholinergic pathways.

Dosage and Administration Information

How to Use Hyosin: Official Administration Guidelines

This section outlines the standard administration instructions for Hyoscine Butylbromide and Hyoscyamine.


Administration Routes and Forms

Drug Type Approved Routes Common Dosage Forms
Hyoscine Butylbromide Oral, Intravenous (IV), Intramuscular (IM) Film-coated tablets (10 mg), Solution for Injection (20 mg/mL)
Hyoscyamine Oral, Sublingual, Intravenous (IV), Intramuscular (IM) Tablets (0.125 mg), Extended-Release (ER) Tablets/Capsules (0.375 mg)

Official Dosing and Handling Instructions

Dosing Frequency: Immediate-release forms of Hyoscyamine are typically taken every four hours as needed, with a maximum daily limit of 1.5 mg for adults. Hyoscine Butylbromide tablets are generally dosed three to four times daily.

Special Handling:

  • Extended-Release (ER) Forms: Hyoscyamine ER tablets or capsules must be swallowed whole. They must not be crushed, split, or chewed to preserve the controlled-release mechanism.
  • Oral Intake: Tablets may be taken with or without food. If taking antacids, they should be taken at least 1 hour after the Hyoscyamine dose.
  • Injection: Hyoscine Butylbromide IV injections must be administered slowly. The solution must be clear and is typically for single use only.

Age-Specific Rules: Dosing for children (e.g., ages 2 to <12 years for Hyoscyamine) requires specific lower dosages and reduced maximum daily limits compared to adult dosing. The use of injectable forms in young children is often cautioned or not recommended.

Recent Clinical Evidence

Research evidence / Overview of Studies for Hyosin


Evidence for Use in Symptomatic Relief of Irritable Bowel Syndrome (IBS)

Research was studied for conditions characterized by fluctuating or episodic manifestations such as Irritable Bowel Syndrome (IBS). Studies include Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews primarily focusing on adults. The research explored outcomes related to physical discomfort, specifically abdominal pain and cramping, used in research exploring how symptoms change over time during short treatment periods.

Studies have reported how symptoms evolved in the observed populations when Hyosin was evaluated in trials against a placebo or active controls. Findings describe patterns observed in the studies related to changes in symptom intensity or variability, but the results showed variability across different meta-analyses. Research provides context but not individual predictions.


Evidence for Use in Acute Abdominal Cramps and Pain

Hyosin was studied for conditions associated with acute or disruptive episodes of abdominal cramping. Research consists primarily of acute, short-term trials conducted in settings where change in pain is monitored over minutes or hours. Studies explored outcomes describing episodic or acute changes, such as the absolute change in pain scores reported by patients shortly after receiving the medicine. Studies monitored the need for rescue analgesia—additional pain medicine—as an outcome related to systemic or functional imbalance.

Studies focusing on episodes where symptoms become more noticeable have findings describe patterns observed in the studies related to changes in pain measurements shortly after administration. However, data show patterns related to variability; reports indicated inconsistency in observed outcomes when the medicine was observed in studies for certain specific acute conditions, such as pain associated with acute gastroenteritis.


Evidence in Special Populations and Clinical Contexts

Research explored the use of Hyosin in specific special populations. For instance, the medicine was evaluated in trials including children aged 6 years and older presenting with acute abdominal spasms. However, data for certain groups remain insufficient. Additionally, Hyosin was studied for its application during labor and delivery. Systematic Reviews and Meta-Analyses research explored whether use of the agent was associated with the duration of the first stage of labor. Findings were mixed; while some older aggregated data suggests a pattern of reduced time in labor, newer, highly-controlled studies did not report the same patterns. Therefore, certainty remains low regarding the research conclusions in this context.

Frequently Asked Questions (FAQ)

Common questions about Hyosin (FAQ)


Q: What is the main thing Hyosin is prescribed for?

Official prescribing information states that this medicine is used primarily for the relief of smooth muscle spasm in the gastrointestinal (stomach and gut) and genitourinary systems. This includes relief of acute cramping pain, such as that associated with renal or biliary colic.


Q: Why do doctors prescribe Hyosin if I have a stomach issue?

When prescribed for a stomach issue, it is used to relieve cramps and spasm-related pain. The medicine works by relaxing the smooth muscles of the digestive system that cause painful, involuntary contractions.


Q: How quickly does Hyosin usually start to work?

According to official data, the onset of action for the oral tablet form is generally rapid. Effects may begin to be noticed within approximately 15 minutes after taking the dose.


Q: How long does the effect of one dose of Hyosin last?

The clinical effect of a single dose of the medicine is reported to last for a duration of approximately 4 to 6 hours. This duration is noted in the product information.


Q: What is the difference between Hyosin and similar generic spasm medications?

The active substance in Hyosin is chemically structured as a quaternary ammonium compound. This specialized chemical structure is key because it helps to restrict its anticholinergic effect primarily to the body's peripheral systems, such as the gut.


Q: Are headaches a common side effect of Hyosin?

Headache has been documented as a reported adverse effect of the medicine. If a persistent or worsening headache is experienced while taking this medication, it is advisable to discuss this with a healthcare professional.


Q: Does Hyosin interact with pain relievers like ibuprofen?

Official drug interaction profiles generally focus on medicines that could increase the anticholinergic effects of Hyosin. No specific interaction is commonly documented between Hyoscine Butylbromide and non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.


Q: Can I take Hyosin if I am also taking an anxiety medication?

It is known that certain types of medications, such as tricyclic antidepressants, may increase the overall anticholinergic effect of Hyosin. Regulatory guidance suggests that a healthcare professional should be aware of all current medications to assess the potential for any additive effects.


Q: Is Hyosin generally considered safe for older adults to use?

Clinical trials have included patients over 65 years of age without reporting adverse reactions specific to this group, but some regulatory documents advise caution in older adults. Contraindications like untreated narrow-angle glaucoma or certain prostatic issues are more common in this population and are key considerations for prescribing clinicians.


Q: Can people with kidney problems use Hyosin?

Caution is advised when the medicine is used in patients with known impaired kidney function. This is because the medicine is substantially processed and excreted by the kidneys.


Q: Is Hyosin appropriate for children, based on official information?

Official information indicates that use of the medicine is generally not recommended for children under 6 years of age. For children 6 years and older, reduced dosing may be used, and any use should only be done under the direction of a qualified healthcare professional.


Q: What are the main warnings listed for Hyosin in official documents?

Official warnings include a detailed list of contraindications, such as untreated narrow-angle glaucoma or certain obstructive bowel conditions like megacolon. Official warnings include a requirement to investigate persistent and unexplained abdominal pain before using the drug. The injection form also carries a risk of serious hypersensitivity reactions.


Q: Is it normal to feel a little dizzy after taking Hyosin?

Yes, official regulatory documents list dizziness as a common side effect of the medicine. This is part of the documented safety profile and is generally related to the drug's anticholinergic activity.


Q: Is Hyosin considered an over-the-counter (OTC) medicine in some places?

The regulatory status varies by country. In some regions, Hyoscine Butylbromide tablets are available for purchase from a pharmacy without a prescription. However, this is often conditional on the symptoms, such as those related to Irritable Bowel Syndrome, having been previously diagnosed by a doctor.


Q: Is Hyosin a controlled substance?

No, the medicine is classified as an antispasmodic and anticholinergic. It is not generally listed as a federally controlled substance (like a narcotic or opioid) in major regulatory markets.


Q: Does Hyosin cause drowsiness that affects driving?

Official warnings state that the medicine may cause drowsiness, dizziness, or blurred vision. Official warnings note that individuals experiencing these side effects should avoid driving or operating any machinery.


Q: What should I know about taking Hyosin before surgery?

The injection form of the medicine is officially indicated for use prior to radiological or diagnostic procedures, such as an endoscopy, where smooth muscle relaxation is required. It is used to temporarily manage spasm during these procedures.


Q: Does Hyosin interact with herbal supplements?

Herbal supplements are not typically included in the detailed official drug interaction tables. However, as with all medications, caution is advised. It is important that a healthcare professional is aware of all supplements being taken.


Q: What is the difference between the brand name and the generic version of Hyosin?

Regulatory information confirms that the generic version contains the same active ingredient, Hyoscine Butylbromide, as the brand-name product. Both contain the same active ingredient and are generally expected to work the same way.


Q: Does Hyosin contain lactose or other common allergens?

Official prescribing information states that the tablets contain lactose monohydrate as an excipient (non-active ingredient). Product labels note that this medicine should not be used by patients with rare hereditary issues involving galactose intolerance or total lactase deficiency.


Q: Do health regulators have any special monitoring programs for Hyosin?

Yes. Regulators continue to monitor the medicine after it has been authorized for use by the public. This involves collecting and reviewing reports of suspected adverse reactions to monitor the ongoing benefit-risk balance of the product.


Q: Is Hyosin a narcotic or opioid?

No. Hyoscine Butylbromide is classified as an antispasmodic/anticholinergic medicine. It belongs to a completely different pharmacological class and does not act on the same receptors as narcotics or opioids.


Q: Why do some sources list different side effects than others for Hyosin?

Differences in side effect lists often depend on the source of the data—either from controlled clinical trials or from post-marketing surveillance. For instance, some side effects are listed as 'frequency not known' because they were reported after authorization, not during the initial clinical studies.


Q: Is Hyosin meant for short-term or long-term use?

The medicine is intended for short-term use to manage symptoms that flare up. Official regulatory guidance states that continuous or extended use should be avoided without a medical investigation into the cause of the symptoms.


Q: Does Hyosin have different uses in different countries?

Yes, official prescribing information and approved uses for medicines can vary between different countries and their respective regulatory jurisdictions.


Q: Are there special dietary restrictions mentioned for people taking Hyosin?

Official guidance notes that the tablets may be taken with or without food. However, a specific instruction is to take antacids at least one hour after the Hyoscyamine dose to prevent any potential absorption issues.

How should Hyosin be stored and disposed of?

Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store at or below 30 C and protect from heat [UK emc, SAHPRA].
Protection Keep out of the sight and reach of children [HPRA, Medsafe].
Packaging Store in the original package to protect the medicine from light and moisture [HPRA].
Injection Use Use immediately after opening the ampoule (single-use only) [UK emc SmPC].
Prohibition Protect the ampoules from freezing [Canada Product Monograph]. Do not store in wet, humid areas like a bathroom [Medsafe].

Disposal Instructions

Official regulatory documents dictate that unused or expired Hyosin must not be thrown away via wastewater or household waste [HPRA]. Disposal of the medicine or any unused contents of an injection ampoule must be done in accordance with local requirements [UK emc SmPC]. Patients are instructed to consult a pharmacist to determine the proper way to discard medicines that are no longer needed [HPRA].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hyosin found in:

A-Z Index: